DR. REDDY'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,955 INR | -0.65% |
|
-1.34% | +2.71% |
| 06-18 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
| 06-18 | Indian Equities Close at Record Highs on Tuesdays, Led by Realty, Private Bank Stocks | MT |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
04:00am
- Investor Meeting - Investec
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
5,955
INR
Average target price
6,114
INR
Spread / Average Target
+2.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.71% | 11.98B | |
| +52.93% | 803B | |
| +40.98% | 629B | |
| -7.08% | 351B | |
| +17.40% | 324B | |
| +10.58% | 303B | |
| +16.42% | 244B | |
| +2.17% | 226B | |
| +10.66% | 215B | |
| +6.24% | 164B |
- Stock Market
- Equities
- DRREDDY Stock
- News Dr. Reddy's Laboratories Limited
- Dr. Reddy's Laboratories Fiscal Q4 Earnings, Revenue Gain
